# ADMELOG

NDC: 0024-5925
Generic name: insulin lispro
Labeler / Manufacturer: Sanofi-Aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20171211

FDA application: BLA209196

## Active ingredients

- INSULIN LISPRO: 100 U/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0024-5925"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0024-5925
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0691def8-4a7b-4de3-866f-a280989f47f1